Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma

BH-15-022
Cancer - Lymphoma, Cancer
Syed Ali, MD

D’Amour Center for Cancer Care

3350 Main Street

Springfield MA 01199


 Franklin Medical Center

164 High Street

Greenfield MA


 

The purpose of this study is to find out what effects, good and/or bad, the addition of lenalidomide to standard chemotherapy (RCHOP)
Newly Diagnosed DiffuseLarge B Cell Lymphoma  expressing CD20 antigen
Katie Colbeck
413-794-9875